TY - JOUR
T1 - PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events
AU - Mendes, Rui D.
AU - Sarmento, Leonor M.
AU - Canté-Barrett, Kirsten
AU - Zuurbier, Linda
AU - Buijs-Gladdines, Jessica G.C.A.M.
AU - Póvoa, Vanda
AU - Smits, Willem K.
AU - Abecasis, Miguel
AU - Yunes, J. Andres
AU - Sonneveld, Edwin
AU - Horstmann, Martin A.
AU - Pieters, Rob
AU - Barata, João T.
AU - Meijerink, Jules P.P.
PY - 2014/7/24
Y1 - 2014/7/24
N2 - Phosphatase and tensin homolog (PTEN)-inactivating mutations and/or deletions are an independent risk factor for relapse of T-cell acute lymphoblastic leukemia (T-ALL) patients treated on Dutch Childhood Oncology Group or German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia protocols. Some monoallelic mutated or PTEN wild-type patients lack PTEN protein, implying that additional PTEN inactivation mechanisms exist. We show that PTEN is inactivated by small deletions affecting a few exons in 8% of pediatric T-ALL patients. These microdeletions were clonal in 3% and subclonal in 5% of patients. Conserved deletion breakpoints are flanked by cryptic recombination signal sequences (cRSSs) and frequently have non-template-derived nucleotides inserted in between breakpoints, pointing to an illegitimate RAG recombination-driven activity. Identified cRSSs drive RAG-dependent recombination in a reporter system as efficiently as bona fide RSSs that flank gene segments of the T-cell receptor locus. Remarkably, equivalent microdeletions were detected in thymocytes of healthy individuals. Microdeletions strongly associate with the TALLMO subtype characterized by TAL1 or LMO2 rearrangements. Primary and secondary xenotransplantation of TAL1-rearranged leukemia allowed development of leukemic subclones with newly acquired PTEN microdeletions. Ongoing RAG activitymay therefore actively contribute to the acquisition of preleukemic hits, clonal diversification, and disease progression.
AB - Phosphatase and tensin homolog (PTEN)-inactivating mutations and/or deletions are an independent risk factor for relapse of T-cell acute lymphoblastic leukemia (T-ALL) patients treated on Dutch Childhood Oncology Group or German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia protocols. Some monoallelic mutated or PTEN wild-type patients lack PTEN protein, implying that additional PTEN inactivation mechanisms exist. We show that PTEN is inactivated by small deletions affecting a few exons in 8% of pediatric T-ALL patients. These microdeletions were clonal in 3% and subclonal in 5% of patients. Conserved deletion breakpoints are flanked by cryptic recombination signal sequences (cRSSs) and frequently have non-template-derived nucleotides inserted in between breakpoints, pointing to an illegitimate RAG recombination-driven activity. Identified cRSSs drive RAG-dependent recombination in a reporter system as efficiently as bona fide RSSs that flank gene segments of the T-cell receptor locus. Remarkably, equivalent microdeletions were detected in thymocytes of healthy individuals. Microdeletions strongly associate with the TALLMO subtype characterized by TAL1 or LMO2 rearrangements. Primary and secondary xenotransplantation of TAL1-rearranged leukemia allowed development of leukemic subclones with newly acquired PTEN microdeletions. Ongoing RAG activitymay therefore actively contribute to the acquisition of preleukemic hits, clonal diversification, and disease progression.
UR - http://www.scopus.com/inward/record.url?scp=84904888382&partnerID=8YFLogxK
U2 - 10.1182/blood-2014-03-562751
DO - 10.1182/blood-2014-03-562751
M3 - Article
C2 - 24904117
AN - SCOPUS:84904888382
SN - 0006-4971
VL - 124
SP - 567
EP - 578
JO - Blood
JF - Blood
IS - 4
ER -